FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

AMPIO PHARMACEUTICALS, INC. — Net Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/8599f062-2f46-413f-8e95-6073e142d470/serie/net-income

Fiscal yearNet IncomePeriodEvidence
FY 2023$-8.6M2023-01-01 – 2023-12-31evidence 0001558370-24-004090
FY 2022$-16.3M2022-01-01 – 2022-12-31evidence 0001558370-23-004723
FY 2021$-17.1M2021-01-01 – 2021-12-31evidence 0001558370-22-004619
FY 2020$-15.9M2020-01-01 – 2020-12-31evidence 0001558370-21-002314
FY 2019$-13.6M2019-01-01 – 2019-12-31evidence 0001558370-20-001123
FY 2018$34.0M2018-01-01 – 2018-12-31evidence 0001558370-20-001123
FY 2017$-51.9M2017-01-01 – 2017-12-31evidence 0001144204-18-013087
FY 2016$-19.2M2016-01-01 – 2016-12-31evidence 0001144204-17-015100
FY 2015$-32.0M2015-01-01 – 2015-12-31evidence 0001193125-16-479780
FY 2014$-38.1M2014-01-01 – 2014-12-31evidence 0001193125-15-059240
FY 2013$-74.5M2008-12-18 – 2014-03-31evidence 0001193125-14-187670
FY 2012$-43.7M2008-12-18 – 2013-03-31evidence 0001193125-13-199383
FY 2011$-30.8M2008-12-18 – 2012-03-31evidence 0001193125-12-211382
FY 2010$-8.1M2010-01-01 – 2010-12-31evidence 0001193125-12-049358
FY 2009$-1.5M2009-01-01 – 2009-12-31evidence 0001193125-12-049358
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

AMPIO PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income